OSCR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

OS

Mkt Cap

$9.85B

Volume

4.39M

Next Earnings

November 5th

Loading chart

OS

OSCROscar Health, Inc.

OSCR

Pay with—

Available Balance0.00

OS

Mkt Cap

$10.33B

Volume

4.39M

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?Oscar Health (OSCR) is positioned as the stronger investment compared to Molina Healthcare (MOH), driven by robust 46% membership growth, 70% revenue increase, a 20% revenue CAGR target through 2027, and a lower valuation multiple. Molina faces headwinds from rising medical costs, enrollment challenges, and portfolio restructuring, with a projected 2027 exit from its MAPD business and $1 billion marketplace premium reduction.Zacks Investment Research · Oct 16, 2026

Are Finance Stocks Lagging ASX Limited - Unsponsored ADR (ASXFY) This Year?ASX Limited - Unsponsored ADR (ASXFY) is significantly outperforming the Finance sector year-to-date, returning 26.3% compared to the sector average of 3.3%. The stock holds a Zacks Rank #1 (Strong Buy) with analyst sentiment improving, as consensus earnings estimates have risen 9.9% in the past quarter. Oscar Health, Inc. (OSCR) is another standout performer in the Finance sector with 132.9% year-to-date returns and a Zacks Rank #1 rating.Zacks Investment Research · Oct 16, 2026

Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and HeicoDespite recent market volatility driven by AI concerns, rising rates, and geopolitical tensions, three stocks with strong Zacks Rank #1 ratings stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and Heico demonstrates consistent aerospace and defense sector strength. All three show improving earnings estimates and constructive technical setups independent of AI boom dependency.Zacks Investment Research · Oct 16, 2026

Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's WhyOscar Health (OSCR) closed at $33.47, down 2.48% on the trading day. The company is rated Zacks Rank #1 (Strong Buy) with an upcoming earnings release on November 5, 2026. Analysts expect EPS of -$0.11 and revenue of $4.72 billion for the quarter, with full-year forecasts of $1.83 EPS and $18.81 billion revenue. The stock trades at a Forward P/E of 18.72, above the industry average of 10.07, with a PEG ratio of 0.38.Zacks Investment Research · Oct 15, 2026

3 Top Ranked Stocks Gaining Despite Market TurmoilAmid market volatility triggered by rising interest rates, inflation concerns, and AI sector weakness, three stocks with strong earnings momentum stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and HEICO demonstrates consistent aerospace and defense sector strength. All three carry Zacks Rank #1 ratings and offer exposure outside the dominant AI investment theme.Zacks Investment Research · Oct 15, 2026

Best Growth Stocks to Buy for October 15thStock markets declined following a higher-than-expected CPI inflation report. The article highlights three stocks with Zacks Rank #1 buy ratings: Petco Health and Wellness (WOOF), Five Below (FIVE), and Oscar Health (OSCR), all showing strong earnings estimate increases and favorable PEG ratios compared to their respective industry averages.Zacks Investment Research · Oct 15, 2026

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key FactsOscar Health (OSCR) closed at $34.32, up 1.57%, outperforming the S&P 500's decline. The company has gained 4.16% over the past month. With an upcoming earnings report expected November 5, 2026, analysts project EPS of -$0.11 and revenue of $4.72 billion. For the full fiscal year, projections show EPS of $1.83 and revenue of $18.81 billion. OSCR holds a Zacks Rank #1 (Strong Buy) rating with consensus EPS projections up 18.79% in the past 30 days, though it trades at a premium valuation with a Forward P/E of 18.43 versus the industry average of 10.09.Zacks Investment Research · Oct 14, 2026

Oscar Health, Inc. (OSCR) is a Top-Ranked Momentum Stock: Should You Buy?Oscar Health (OSCR), a healthcare technology company offering ACA health plans, has been identified as a strong momentum stock with a Zacks Rank #1 (Strong Buy) rating and a VGM Score of A. The company has seen three upward earnings estimate revisions in the last 60 days, with consensus estimates increasing to $1.83 per share for fiscal 2026, and shares are up 4.2% over the past four weeks.Zacks Investment Research · Oct 14, 2026

This Top Finance Stock is a #1 (Strong Buy): Why It Should Be on Your RadarOscar Health, Inc. (OSCR) has been added to the Zacks Rank #1 (Strong Buy) list on September 23, 2026. The healthcare technology company has received upward earnings estimate revisions from three analysts, with consensus estimates increasing to $1.83 per share. Analysts expect 208.3% earnings growth and 60.8% revenue growth for the current fiscal year, with the stock up 4.2% over the past four weeks.Zacks Investment Research · Oct 14, 2026

Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value InvestorsOscar Health (OSCR) is highlighted as an attractive investment opportunity combining momentum with value. The stock has gained 4.2% over four weeks and 9.8% over 12 weeks, with a beta of 2.47 indicating high volatility. Despite strong momentum metrics and a Zacks Rank #1 (Strong Buy) rating driven by upward earnings estimate revisions, OSCR trades at a reasonable valuation with a Price-to-Sales ratio of 0.68, suggesting significant upside potential.Zacks Investment Research · Oct 14, 2026

to start trading

OS

OSCROscar Health, Inc.

OSCR

Pay with—

Available Balance0.00

Your PositionYou don't own any OSCR yet.

Related Tickers

Earnings